About us Services Careers Contact us Privacy A new European pharmaceutical company based on a solid heritage 01. November 2021 Coripharma adds Senior Sourcing Manager and Portfolio Manager to the growing team Coripharma today announced that Stefan Karlsson is joining the company as Senior Sourcing Manager an... 02. September 2021 Coripharma adds 7mg strength to recent Teriflunomide dossier Responding swiftly to customer demand, CORIPHARMA has completed the development of Teriflunomide 7mg... SERVICES Coripharma offers a wide range of CDMO services We specialize in developing and manufacturing solid oral dosage forms, packaging, testing, EU releasing and co-develoment. In 2018 Coripharma acquired the Actavis manufacturing site in Iceland A group of former Actavis employees, along with investors, acquired Actavis Iceland in order to continue high quality pharmaceutical production MANUFACTURING Manufacturing capability The manufacturing capacity of the site is about 1.2bn tablets / capsules per year. The factory is equipped with manufacturing, packaging and laboratory equipment. ENVIRONMENT Environment Our facility in Iceland uses only green energy from sustainable sources; geothermal and hydropower. When you browse on this site, cookies collect data to enhance your experience. Visit our privacy policy (updated 15 APR 2019) and consent tool to learn more, and make choices about the data used. By clicking "Accept" or by continuing to use the site, you agree to this use of cookies and data. Privacy policy Consent tool Accept About us Services Careers Contact us Privacy Coripharma Reykjavikurvegur 78 - 80 220 Hafnarfjordur, Iceland Email info@coripharma.is Phone +354 4206700